Keros Therapeutics, Inc. (KROS): Form 8-K filed 2026-07-22
- Accepted by EDGAR
- 2026-07-22 16:01 ET
- Event date
- 2026-07-17
- Accession no.
- 0001664710-26-000038
- Original filing
- SEC EDGAR filing index
Items reported
- Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
A director or a named officer (such as the CEO or CFO) left or was appointed, or certain executive compensation arrangements were adopted or changed.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | kros-20260717.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.